Welcome to our dedicated page for Cnl Healthcare SEC filings (Ticker: CHTH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for CNL Healthcare Properties, Inc. (CHTH) brings together the company’s regulatory disclosures, including Form 8‑K reports detailing its planned acquisition by Sonida Senior Living, Inc. and related corporate actions. These filings are central for understanding how the company describes the multi‑step merger structure, the plan of liquidation, and the conditions required for closing the Transactions.
In its Form 8‑K dated November 4, 2025, CNL Healthcare Properties, Inc. outlines the Agreement and Plan of Merger with Sonida Senior Living, Inc. and affiliated entities. The filing explains how equity interests in certain subsidiaries will be sold, how merger steps will be sequenced, and how each share of company common stock is expected to be converted into a combination of Sonida common stock and cash, subject to the terms of the Merger Agreement. It also describes termination rights, potential termination fees, and covenants such as maintaining REIT status and conducting business in the ordinary course.
A later Form 8‑K dated January 12, 2026, reports an unsolicited mini‑tender offer by MacKenzie Capital Management, LP to purchase a limited number of shares of CNL Healthcare Properties, Inc. common stock at a specified price. The company’s board determined to remain neutral regarding whether stockholders should tender shares, and a letter to stockholders explaining this position is furnished as an exhibit.
On this page, users can access such filings as they are made available through the SEC’s EDGAR system, including annual reports on Form 10‑K, quarterly reports on Form 10‑Q, and current reports on Form 8‑K referenced in the company’s disclosures. Stock Titan’s tools can assist by highlighting key sections, summarizing complex transaction terms, and helping readers quickly identify information on the Transactions, the plan of liquidation, and other material events affecting CNL Healthcare Properties, Inc.
CNL Healthcare Properties director and officer Stephen H. Mauldin disposed of 6,133 shares of common stock in a transaction with the company. This disposition occurred in connection with the closing of a merger under an Agreement and Plan of Merger involving CNL Healthcare Properties and Sonida Senior Living.
For each CNL share held, Mauldin received 0.1318 of a Sonida Senior Living common share plus cash in lieu of fractional shares on March 10, 2026, and $2.32 in cash on March 11, 2026, for total consideration of $4.74 per share, based on a ten-day volume-weighted average price. After this merger-related transaction, he no longer held CNL common shares.
CNL Healthcare Properties, Inc. director and chairman James M. Seneff Jr. disposed of 1,370,820 shares of common stock back to the company in connection with the closing of a previously signed merger agreement.
For each share surrendered, he received 0.1318 Sonida Senior Living (SNDA) shares plus cash in lieu of fractional shares on March 10, 2026, and an additional $2.32 in cash per share on March 11, 2026, for total merger consideration of $4.74 per share based on the defined closing VWAP. Following this merger-driven disposition, his directly held CNL Healthcare common stock position reported in this filing is 0 shares.
CNL Healthcare Properties, Inc. filed its audited consolidated financial statements and auditor’s report, providing a detailed view of its 2025 results and balance sheet.
For 2025, the company generated total revenues of $392.6 million, up from 2024, and reported a net loss attributable to common stockholders of $8.8 million, or $(0.05) per share. Net operating income was $112.1 million, while interest expense and loan cost amortization totaled $43.6 million.
At December 31, 2025, real estate investment properties, net, were carried at $1.21 billion, total assets were $1.29 billion, and total stockholders’ equity was $686.2 million. Cash and restricted cash were $57.7 million, and total indebtedness under credit facilities was $563.9 million, maturing in May 2026.
The notes highlight a pending merger with Sonida Senior Living, Inc. valued at approximately $1.80 billion, under which each share of the company’s common stock will receive Sonida stock based on a defined exchange ratio plus $2.32 in cash, with closing expected March 11, 2026, subject to conditions.
CNL Healthcare Properties, Inc. reported results from its Annual Meeting of Stockholders held on March 6, 2026. Stockholders approved the merger-related transactions under the November 4, 2025 Agreement and Plan of Merger, with 90,380,525 votes for, 1,006,023 against, and 2,748,471 abstaining.
The company achieved a quorum, as 94,135,019 shares (53.7%) of the 175,274,045 common shares outstanding as of December 30, 2025 were represented. All five director nominees were elected to serve until the 2027 Annual Meeting or until the transactions are consummated, and PricewaterhouseCoopers LLP was ratified as independent auditor for the year ending December 31, 2025.
CNL Healthcare Properties, Inc. furnished an investor presentation after hosting a webinar that updates stockholders on its business, strategic process and the seniors housing market. The materials highlight that the company has raised $1.7B of capital since launch, invested about $1.74B, and currently holds 70 investments, mainly 69 needs-based seniors housing communities across 26 states, with net asset value of $6.90 per share as of November 4, 2025 and annualized first-quarter 2026 distributions of $0.1024 per share, or 1.48%. The presentation reviews the strategic alternatives process begun in 2018, during which 73 properties were sold for nearly $1.52B in gross proceeds and a special distribution of $2.00 per share was paid in May 2019. It also describes the proposed combination with Sonida Senior Living, noting a pro forma enterprise value of about $3.0B, 153 owned senior housing properties and roughly 14,700 owned units, along with expected G&A synergies of $16–$20M. Sector slides emphasize four consecutive years of occupancy increases of more than 200 basis points and record-low inventory growth in 2025, while extensive risk disclosures outline the illiquidity of non-traded REIT shares, sensitivity to senior housing demand, use of leverage, advisor conflicts, distribution uncertainty and other business risks.
CNL Healthcare Properties updated investors on its planned merger with Sonida Senior Living and its latest valuation. The board set an adjusted estimated net asset value of $6.90 per share as of November 4, 2025, matching the aggregate cash-and-stock consideration in the pending Sonida acquisition, which is valued at approximately $1.8 billion. This NAV is meant to guide account statement reporting and reflects the merger terms rather than an independent new appraisal process.
The company currently anticipates closing the transaction in March 2026, subject to stockholder approvals and other customary conditions, and emphasizes that the deal may be delayed or not occur. The board also declared a prorated regular quarterly distribution of $0.02133 per share for the first quarter through March 16, 2026, payable on or about February 18, 2026 to stockholders of record as of February 13, 2026. If the merger does not proceed, the company expects to engage an independent valuation firm to reassess its NAV.
CNL Healthcare Properties filed a supplemental disclosure related to its planned merger with Sonida Senior Living after two stockholder lawsuits and additional demand letters challenged the adequacy of prior proxy disclosures. The companies dispute the claims but are voluntarily expanding details to reduce litigation risk.
The filing adds specifics on 12-month standstill and “don’t ask, don’t waive” provisions in 2025 confidentiality agreements, valuation work by RBC Capital Markets, and projected 2025–2030 standalone revenue, EBITDA, adjusted EBITDA, free cash flow and net operating loss utilization for SNDA. These changes do not alter merger consideration or the timing of CHP’s March 6, 2026 stockholder meeting, and CHP’s board continues to recommend voting “FOR” all proposals.
CNL Healthcare Properties filed an update related to its planned merger with Sonida Senior Living. The company reports that two stockholder lawsuits and additional demand letters allege disclosure issues in the joint proxy statement. While denying any merit, CHP and SNDA are voluntarily supplementing disclosures to avoid delays and costs.
The supplements add detail on confidentiality agreements with 12‑month standstill and “don’t ask, don’t waive” provisions, valuation multiples used by RBC Capital Markets, and discounted cash flow assumptions, including perpetuity growth and discount rate ranges. They also provide SNDA standalone projections for revenue, EBITDA, adjusted EBITDA, unlevered free cash flow and net operating loss utilization through 2035. The consideration for CHP stockholders and the March 6, 2026 annual meeting timing remain unchanged, and the CHP board continues to recommend voting in favor of the merger proposals.
CNL Healthcare Properties, Inc. reports that MacKenzie Capital Management has launched an unsolicited mini‑tender offer to buy up to 400,000 common shares, about 0.23% of outstanding shares, at $4.55 per share. The company states it is not affiliated with MacKenzie or the offer.
After consulting management and outside advisors, the Board of Directors unanimously chose to make no recommendation and remain neutral on whether stockholders should tender. On January 14, 2026, the company posted a letter to stockholders explaining this neutral position.
The company notes that some investors may value the offer’s fixed cash price given the suspension of its stock redemption plan, lack of a trading market, and the proposed transactions with Sonida Senior Living, Inc., where part of the consideration would be Sonida shares whose value can change. The filing also highlights extensive forward‑looking risks around closing the Sonida transactions, required approvals, potential litigation, costs, and possible termination of the definitive agreement.